Diploma (LON:DPLM – Free Report) had its target price boosted by JPMorgan Chase & Co. from GBX 4,370 ($53.35) to GBX 4,420 ($53.96) in a report published on Tuesday, Marketbeat Ratings reports. They currently have a neutral rating on the stock.
A number of other equities analysts also recently commented on the company. Shore Capital downgraded Diploma to a “hold” rating in a research report on Tuesday, November 19th. Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a GBX 5,100 ($62.26) target price on shares of Diploma in a research note on Friday, November 22nd. Two equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to MarketBeat, Diploma presently has a consensus rating of “Moderate Buy” and an average target price of GBX 4,567.50 ($55.76).
Read Our Latest Research Report on DPLM
Diploma Trading Up 2.9 %
Diploma Increases Dividend
The firm also recently disclosed a dividend, which will be paid on Friday, January 31st. Investors of record on Thursday, January 16th will be issued a GBX 42 ($0.51) dividend. The ex-dividend date is Thursday, January 16th. This is a boost from Diploma’s previous dividend of $17.30. This represents a yield of 0.93%. Diploma’s dividend payout ratio is currently 6,627.91%.
Insider Buying and Selling
In other news, insider Johnny Thomson sold 26,794 shares of the business’s stock in a transaction that occurred on Tuesday, November 19th. The shares were sold at an average price of GBX 4,536 ($55.38), for a total value of £1,215,375.84 ($1,483,794.21). Also, insider Chris Davies acquired 3,917 shares of the firm’s stock in a transaction dated Friday, December 20th. The stock was bought at an average price of GBX 4,280 ($52.25) per share, for a total transaction of £167,647.60 ($204,672.93). 0.52% of the stock is currently owned by company insiders.
Diploma Company Profile
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Further Reading
- Five stocks we like better than Diploma
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- What is the Shanghai Stock Exchange Composite Index?
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Diploma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Diploma and related companies with MarketBeat.com's FREE daily email newsletter.